June 25, 2020 / 6:13 AM / 9 days ago

BRIEF-Oryzon Approves Share Capital Increase For An Effective Amount Of 20 Mln Euros

June 25 (Reuters) - Oryzon Genomics SA:

* SAYS TO RUN SHARE CAPITAL INCREASE FOR EFFECTIVE AMOUNT OF 20 MILLION EUROS THROUGH ISSUANCE OF 7.3 MILLION NEW SHARES

* SAYS ISSUE PRICE IS 2.75 EUROS PER SHARE OF WHICH 2.70 EUROS PER SHARE CORRESPOND TO ISSUE PREMIUM

* SAYS PURPOSE OF CAPITAL INCREASE IS TO FINANCE RESEARCH AND DEVELOPMENT OF ITS CLINICAL PROGRAMS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below